article thumbnail

San Diego's Seismic Snags $100M, Joins Unicorns

socalTECH

San Diego-based Seismic , a developer of sales and marketing software, has raised $100M more in a funding round, which values the company at $1 billion, the company said on Tuesday. The funding round came from Lightspeed Venture Partners, T. Rowe Price, plus General Atlantic, JMI Equity, and Jackson Square Ventures.

San Diego 113
article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 Composite Capital Master Fund, and Navistar. per share, raising just over $1 billion for the company. Piper Sandler and Valuable Capital.

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Odonate Therapeutics Prices IPO

socalTECH

San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 The $24.00 READ MORE>>.

Pricing 113
article thumbnail

Arena Pharmaceuticals Spins Off Longboard Pharmaceuticals With $56M Funding

socalTECH

San Diego-based Arena Pharmaceuticals announced this morning that it has launched a new company, Longboard Pharmaceuticals , with $56M in funding. The new funding comes from Farallon Capital, Cormorant Asset Management, HBM Healthcare Investments, Highside Capital Management, and T.

Funding 113
article thumbnail

San Diego Life Sciences Roundup: Evofem, Cullgen, BrainLeap & More

Xconomy

Locally based biotech companies receive fresh funding from investors. Get the details on these developments and more in San Diego life sciences news: —Evofem Biosciences (NASDAQ: EVFM ) struck a deal to raise up to $80 million in a private placement. million shares.

article thumbnail

AnaptysBio Sets Estimated IPO Pricing Range

socalTECH

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. READ MORE>>.

Pricing 100
article thumbnail

Ambit Biosciences Prices IPO

socalTECH

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 Ambit priced well below its estimated initial public offering range, which had been set at between $13.00 The company will start trading today on the NASDAQ Global Market as AMBI. and $15.00

Pricing 138